Arcturus Therapeutics Holdings Inc. (ARCT) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-10-26
4:44 pm
Sale		2021-10-2113DArcturus Therapeutics Holdings Inc.
ARCT		Ultragenyx Pharmaceutical Inc.
RARE		1,200,000
4.600%		-200,000decrease
(-14.29%)		Filing
History
2021-08-12
5:09 pm
Sale		2021-08-1013DArcturus Therapeutics Holdings Inc.
ARCT		Ultragenyx Pharmaceutical Inc.
RARE		1,400,000
5.300%		-800,000decrease
(-36.36%)		Filing
History
Goto Prev, 0, 1, 2